高剂量维生素D3补充对糖尿病前期受试者骨密度的影响
本研究为一项已完成的试验的二次分析,511例糖尿病前期受试者随机接受维生素D3(每周20,000 IU)或安慰剂治疗5年,采用双能X线吸收法测量骨密度。结果显示,男性维生素D组股骨颈骨密度下降显著少于对照组(0.000 vs -0.010 g/cm2,p=0.008),全髋部位男女均无显著差异。作者认为维生素D3单药补充可能对糖尿病前期男性有益,但需验证性研究。
要点
- 糖尿病前期男性接受维生素D3每周20,000 IU治疗5年,股骨颈骨密度下降显著少于安慰剂组。
- 全髋部位骨密度在男女两组中均未见显著组间差异。
- 作者认为维生素D3单药补充可能对糖尿病前期男性有益,但需验证性研究。
核心结论
- 维生素D3单药补充可能对糖尿病前期男性有益,但需验证性研究。
研究设计与样本
- 本研究为对一项已完成的试验进行的二次研究,该试验将511例糖尿病前期受试者随机分配至维生素D3(每周20,000 IU)组或安慰剂组,疗程5年。
- 骨密度采用双能X线吸收法(DEXA)测量。
主要发现
- 256例受试者随机分配至维生素D组,255例至安慰剂组。
- 基线平均血清25-羟基维生素D(25(OH)D)水平为60 nmol/L。
- 维生素D组和安慰剂组分别有202例和214例完成骨密度测量,每组各有1例因使用双膦酸盐被排除。
- 男性维生素D组股骨颈骨密度下降显著少于对照组(0.000 vs -0.010 g/cm2,p=0.008)。
- 全髋测量部位男女两组均未见干预组间显著差异。
局限性
- 作者指出本研究的临床意义需进一步研究。
- 作者结论指出需验证性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The rationale of this study was to determine the effect of high-dose vitamin D3 supplementation on bone mineral density (BMD). Prediabetic males given vitamin D had significantly less reduction in BMD at the femoral neck compared to the controls. The clinical implications of our findings require further investigation. INTRODUCTION: Type 2 diabetes mellitus is associated with increased fracture risk, and recent studies show crosstalk between bone and glucose metabolism. Few studies have investigated the effect of vitamin D supplementation on the bone without additional calcium. In the present study, we aimed to determine whether a high dose of vitamin D3 could improve bone mass density (BMD) in prediabetic subjects. METHODS: The current study was conducted as a secondary research on a previously performed trial, in which 511 subjects with prediabetes were randomized to vitamin D3 (20,000 IU per week) versus placebo for 5 years. BMD was measured using dual-energy X-ray absorptiometry (DEXA). RESULTS: Two hundred and fifty-six subjects were randomized to vitamin D and 255 to placebo. Mean baseline serum 25-hydroxyvitamin D (25(OH)D) level was 60 nmol/L. Two hundred and two and 214 in the vitamin D and placebo groups, respectively, completed BMD measurements, whereas one in each group was excluded due to use of bisphosphonates. Males given vitamin D had significantly less reduction in BMD at the femoral neck measurement site compared to the controls (0.000 versus - 0.010 g/cm2, p = 0.008). No significant differences between intervention groups were seen at the total hip measurement site, regarding both males and females. CONCLUSIONS: Vitamin D3 supplementation alone may be beneficial in males with prediabetes, but confirmatory studies are needed.
引用
- Larsen AU, Grimnes G, Jorde R, et al. The effect of high-dose vitamin D3 supplementation on bone mineral density in subjects with prediabetes. Osteoporos Int. 2017. PMID: 28921338. doi:10.1007/s00198-017-4222-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。